Related references
Note: Only part of the references are listed.Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Jing Lu et al.
CLINICAL CANCER RESEARCH (2009)
Transcriptional regulation of BRD7 expression by Sp1 and c-Myc
Huaying Liu et al.
BMC MOLECULAR BIOLOGY (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester IMPLICATIONS FOR F1F0 ATPase REGULATION
Tiffany Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Causes and consequences of increased glucose metabolism of cancers
Robert J. Gillies et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1
Ma Khaleque et al.
ONCOGENE (2008)
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis
Chengkai Dai et al.
CELL (2007)
Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors
J-N Min et al.
ONCOGENE (2007)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The Warburg effect and its cancer therapeutic implications
Zhao Chen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Glycolysis in cancer: A potential target for therapy
Robert A. Gatenby et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Glycolysis inhibition for anticancer treatment
H. Pelicano et al.
ONCOGENE (2006)
Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCa and Src inhibitors
M. Tan et al.
ONCOGENE (2006)
Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide
M Tan et al.
CANCER RESEARCH (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Heat shock response modulators as therapeutic tools for diseases of protein conformation
SD Westerheide et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
A Rarnanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ErbB2 promotes Src synthesis and stability: Novel mechanisms of Src activation that confer breast cancer metastasis
M Tan et al.
CANCER RESEARCH (2005)
Agonist-activated glucocorticoid receptor inhibits binding of heat shock factor 1 to the heat shock protein 70 promoter in vivo
SA Wadekar et al.
MOLECULAR ENDOCRINOLOGY (2004)
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
XY Zhou et al.
CLINICAL CANCER RESEARCH (2004)
Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis
M Tan et al.
MOLECULAR CELL (2002)
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
J Rutter et al.
SCIENCE (2001)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
